Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Anticoagulant Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02946944
What this trial is testing

Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism

Who this might be right for
Pulmonary EmbolismIntermediate-high RiskCombination of Oral Anticoagulation Therapy and Sildenafil
Meshalkin Research Institute of Pathology of Circulation 100
Not applicableNot Yet RecruitingNCT06290440
What this trial is testing

MEdication Counselling Models for Outpatient oRal antIcoaguLation

Who this might be right for
Anticoagulants; Circulating, Hemorrhagic Disorder
Gia Dinh People Hospital 360
Not applicableUnknownNCT02635230
What this trial is testing

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.

Who this might be right for
Atrial FibrillationsHeart Valve ProsthesesAcute Coronary Syndromes+4 more
R&D Cardiologie 2,200
Testing effectiveness (Phase 2)Study completedNCT00684307
What this trial is testing

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Who this might be right for
Nonvalvular Atrial Fibrillation
AstraZeneca 1,084
Large-scale testing (Phase 3)Looking for participantsNCT05387954
What this trial is testing

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Who this might be right for
Cryptogenic Ischemic StrokePatent Foramen Ovale
Assistance Publique - Hôpitaux de Paris 792
Not applicableWithdrawnNCT04508855
What this trial is testing

Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)

Who this might be right for
CancerAtrial Fibrillation
AHEPA University Hospital
Not applicableStudy completedNCT04662515
What this trial is testing

NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

Who this might be right for
Surgery, OralHemorrhagePostoperative Complications+3 more
Malmö University 216
Post-approval studies (Phase 4)Study completedNCT00222638
What this trial is testing

Influenza Vaccination and Oral Anticoagulant Therapy

Who this might be right for
AnticoagulantsInfluenza Vaccines
University Of Perugia 100
Not applicableUnknownNCT05332158
What this trial is testing

Medicines Gaps Study

Who this might be right for
Adherence, MedicationStatin Adverse ReactionAnticoagulant Adverse Reaction
The Leeds Teaching Hospitals NHS Trust 3,000
Large-scale testing (Phase 3)Study completedNCT02801669
What this trial is testing

Study of DU-176b Aged 80 Years or Older

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Co., Ltd. 984
Testing effectiveness (Phase 2)Study completedNCT02223260
What this trial is testing

Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 8
Post-approval studies (Phase 4)Study completedNCT04483583
What this trial is testing

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Who this might be right for
Coronary Artery Disease
University of Florida 81
Not applicableUnknownNCT03666962
What this trial is testing

Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation

Who this might be right for
AnticoagulantsCompliance, Medication
Cui Yimin 200
Not applicableStudy completedNCT03583008
What this trial is testing

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF

Who this might be right for
Atrial FibrillationPrescribing PracticesAnticoagulants
University of Massachusetts, Worcester 112
Large-scale testing (Phase 3)Study completedNCT00345618
What this trial is testing

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

Who this might be right for
EmbolismThrombosis
Sanofi 3,202
Not applicableActive Not RecruitingNCT04676880
What this trial is testing

Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy

Who this might be right for
Atrial FibrillationAnticoagulants and Bleeding Disorders
R&D Cardiologie 609
Not applicableStudy completedNCT05022563
What this trial is testing

Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea

Who this might be right for
Venous Thromboembolism
Pfizer 55,759
Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Not applicableStudy completedNCT07523347
What this trial is testing

Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis

Who this might be right for
Cerebrosinovenous Thrombosis
Muhammad Aamir Latif 75
Not applicableStudy completedNCT01033279
What this trial is testing

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy

Who this might be right for
AnticoagulantsQuality of LifeDrug Monitoring+2 more
Montreal Heart Institute 120
Next Page